Inventor · disambiguated record
Dmitry Dmitrievich Genkin
Also filed as: GENKIN DMITRY · GENKIN DMITRY D · GENKIN DMITRY DMITRIEVICH
22 granted patents·20 pending applications·291 citations·filing 1996–2024
96Inventor score
Files withCLS THERAPEUTICS LTD18GENKIN DMITRY DMITRIEVICH8LIPOXEN TECH LIMITED6GENKIN DMITRY D2Hesperix SA2
Top patents by PatentIndex Score
42 records- 0196US9845461B2Method for treating oncological diseasesCLS THERAPEUTICS LTD·Filed 2016·Granted Dec 19, 2017·14 cites·4 claims
- 0296US9248166B2Method for treating oncological diseasesCLS THERAPEUTICS LTD·Filed 2014·Granted Feb 2, 2016·20 cites·4 claims
- 0396US8535663B2Method for treating delayed-type hypersensitivityCLS THERAPEUTICS LTD·Filed 2013·Granted Sep 17, 2013·28 cites·3 claims
- 0496US8431123B2Method for treating systemic bacterial, fungal and protozoan infectionGENKIN DMITRY DMITRIEVICH·Filed 2010·Granted Apr 30, 2013·32 cites·23 claims
- 0595US9770492B2Method for treating systemic DNA mutation diseaseCLS THERAPEUTICS LTD·Filed 2016·Granted Sep 26, 2017·17 cites·5 claims
- 0695US8796004B2Method for treating systemic DNA mutation diseaseCLS THERAPEUTICS LTD·Filed 2013·Granted Aug 5, 2014·20 cites·4 claims
- 0795US8388951B2Method for treating systemic DNA mutation diseaseGENKIN DMITRY DMITRIEVICH·Filed 2010·Granted Mar 5, 2013·27 cites·4 claims
- 0893US9072733B2Method for treating systemic bacterial, fungal and protozoan infectionCLS THERAPEUTICS LTD·Filed 2013·Granted Jul 7, 2015·12 cites·2 claims
- 0992US10617743B2Method to improve safety and efficacy of anti-cancer therapyCLS THERAPEUTICS LTD·Filed 2015·Granted Apr 14, 2020·6 cites·15 claims
- 1092US8916151B2Method for treating a reduction of fertilityGENKIN DMITRY DMITRIEVICH·Filed 2005·Granted Dec 23, 2014·26 cites·5 claims
- 1191US7612032B2Method for treating oncological diseasesGENKIN DMITRY DMITRIEVICH·Filed 2004·Granted Nov 3, 2009·55 cites·7 claims
- 1287US8871200B2Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said methodGENKIN DMITRY DMITRIEVICH·Filed 2006·Granted Oct 28, 2014·12 cites·8 claims
- 1387US8710012B2Method for treating oncological diseasesGENKIN DMITRY DMITRIEVICH·Filed 2010·Granted Apr 29, 2014·7 cites·4 claims
- 1486US9463223B2Method for monitoring development of somatic mosaicismCLS THERAPEUTICS LTD·Filed 2014·Granted Oct 11, 2016·4 cites·5 claims
- 1580US2025064901A1Method to improve safety and efficacy of anti-cancer therapyCLS THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1679US11905522B2Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activityCLS THERAPEUTICS LTD·Filed 2019·Granted Feb 20, 2024·1 cites·6 claims
- 1779US7718589B2Method for washing the face skin and a composition for carrying out said methodGENKIN DMITRY DMITRIEVICH·Filed 2005·Granted May 18, 2010·1 cites·3 claims
- 1877US10188739B2Compositions and methods for administering insulin or insulin-like protein to the brainXENETIC BIOSCIENCES INC·Filed 2015·Granted Jan 29, 2019·2 cites·19 claims
- 1976US11701410B2Extracellular DNA as a therapeutic target in neurodegenerationCLS THERAPEUTICS LTD·Filed 2016·Granted Jul 18, 2023·1 cites·30 claims
- 2072US2024425879A1Compositions and methods for adeno-associated (aav) virus dnase expressionCLS THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 2168US2024245758A1Immunomodulation of tumor microenvironmentCLS THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 2267US2017056482A1Method for treating systemic dna mutation diseaseCLS THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 2366US2020188493A1Method to improve safety and efficacy of anti-cancer therapyCLS THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 2466US2021401999A1Methods of treating diseases related to net formation with parenteral administration of polysialylated dnase iLIPOXEN TECH LIMITED·Filed 2021·Application pending·0 cites
- 2565US2022008544A1Methods of treating multiple myeloma cancers expressing high levels of epo-receptor using psa-epoLIPOXEN TECH LIMITED·Filed 2021·Application pending·0 cites
- 2660US2024216483A1Therapeutic regimen with dnasePERI NESS TECH LTD·Filed 2022·Application pending·0 cites
- 2759US2019083636A1Methods of treating diseases related to net formation with parenteral administration of polysialylated dnase iLIPOXEN TECH LIMITED·Filed 2018·Application pending·0 cites
- 2858US2008004561A1Method for Treating Oncological, Virulent and Somatic Diseases, Method for Controlling Treatment Efficiency, Pharmaceutical Agents and Composition for Carrying Out Said TreatmentGENKIN DMITRY D·Filed 2005·Application pending·0 cites
- 2956US2025170241A1Chimeric antigen receptor t-cell treatments targeted to chromatin fragments and extracellular trapsBELGIAN VOLITION SRL·Filed 2023·Application pending·0 cites
- 3055US2024050476A1Combination of deoxyribonuclease enzyme and cell therapies for treatment of cancerCLS THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 3154US11215618B2Articles and methods directed to personalized therapy of cancerHesperix SA·Filed 2020·Granted Jan 4, 2022·0 cites·13 claims
- 3254US2015110769A1Method for retarding unhealthy manifestations brought by ageing of human beingsCLS THERAPEUTICS LTD·Filed 2014·Application pending·0 cites
- 3352US2020271657A1Articles and methods directed to personalized therapy of cancerSTEPANOV ALEXEY VYACHESLAVOVICH·Filed 2018·Application pending·0 cites
- 3452US2022241394A1TREATMENT OF DISEASES ASSOCIATED WITH PROTEIN MISFOLDING BY NERVOUS SYSTEM EXPRESSION OF AN ENZYME WHICH HAS A DEOXYRIBONUCLEASE (DNase) ACTIVITYCLS THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 3550US2020179524A1Methods of treating multiple myeloma cancers expressing high levels of epo-receptor using psa-epoLIPOXEN TECH LIMITED·Filed 2018·Application pending·0 cites
- 3649US12111319B2Articles and methods directed to personalized therapy of cancerHesperix SA·Filed 2021·Granted Oct 8, 2024·0 cites·10 claims
- 3747US2007104702A1Method for treating diseases associated with changes of qualitative and/quantitative composition of blood extracellular dnaGENKIN DMITRY D·Filed 2004·Application pending·0 cites
- 3846US2022023430A1Glycopolysialylation of blinatumomabLIPOXEN TECH LIMITED·Filed 2019·Application pending·0 cites
- 3945US10406150B2Method for treatment of primary hormone resistant endometrial and breast cancersLIPOXEN TECH LIMITED·Filed 2017·Granted Sep 10, 2019·0 cites·13 claims
- 4043US2021069242A1Reprogramming of polymorphonuclear leukocytesGENKIN DMITRY DMITRIEVICH·Filed 2020·Application pending·0 cites
- 4142US2017100463A1Method to improve safety and efficacy of anti-cancer therapyCLS THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 4234US5965623AAnti-glucocorticoid drugFiled 1996·Granted Oct 12, 1999·6 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Dmitry Dmitrievich Genkin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →